1 Growth Stock Down 15.8% to Buy Right Now

A growth stock is well-positioned to resume its upward momentum in 2024 following its strong financial results and business momentum.

| More on:
Dad and son having fun outdoor. Healthy living concept

Image source: Getty Images

The healthcare market and wellness industry generally experienced a boom during the global pandemic. COVID-19 motivated nearly everyone to prioritize health, protect immune systems, and change lifestyles. Investors gravitated towards the healthcare sector and other stocks in various sectors with health-related businesses.

Jamieson Wellness (TSX:JWEL) rose to prominence at the height of the coronavirus breakout. Investors suddenly focused on the manufacturer, distributor, and seller of natural health products. In 2020, the consumer-defensive stock delivered a fat 42.4% capital gain.

Growth stock

A promising growth stock was born during the COVID period. Because of the heightened interest in health and wellness products, Jamieson’s revenue in 2020 increased 17% to $403.7 million versus 2019, while net income rose 31.4% year over year to $41.6 million.

Its President and CEO then, Mark Hornick, said more than three years ago, “The COVID-19 pandemic has elevated health and wellness to become the top priority for consumers globally, and we are grateful for the role our brands play in supporting our consumers’ foundational health.”    

Post-pandemic, investors’ interest in Jamieson waned, although it has remained profitable since 2020. Today, at $26.56 per share, the $1.1 billion company also pays a decent 2.66% dividend. Unfortunately, the stock trades at a discount (-15.8% year to date). Fortunately, the stalled growth could resume in 2024 and beyond.

Strong financial results

In Q4 2023, revenue and net earnings climbed 14.3% and 8.6% respectively to $220.4 million and $24 million versus Q4 2022. While the top line last year grew 23.5% year over year to $676.2 million, net earnings declined 12.8% to $46 million compared to 2022.

Still, current President and CEO Mike Pilato said, “2023 was a reflection of success on our strategic journey to become a global vitamin, mineral, and supplement leader. We drove growth across all our major markets and business units while successfully completing our 2022 U.S. acquisition integration and taking ownership of the full value chain in China.”

Pilato said further, “We are entering 2024 from a position of strength – strategically, operationally, and financially.” The diversification strategy and journey to expand the global footprint and increase market share beyond the home country are ongoing. Notably, international markets account for 40% of total branded revenue.

Jamieson will continue to prioritize investment in demand generation, innovation, and distribution in all our major markets to harness the full potential of the evolving needs of engaged consumers and significant industry growth tailwinds. Expect aggressive investments to grow its brands in the U.S. and China.

Business Outlook

For 2024, Jamieson Wellness projects consolidated revenue between $720 million and $760 million, or roughly 6.5% to 12.5% growth. The revenue growth guidance for Jamieson is from 12% to 18% or from $615 million to $650 million. Furthermore, business growth in the U.S. (13% to 20%) and China (60% to 80%) will outperform the Canadian market (4% to 7.5%).

After this year or in 2025, management anticipates a return to low double-digit growth, although Jamieson Brands will continue to drive growth and profitability. The company’s broad product scope and strong innovation capabilities enable it to respond to changing consumer trends, preferences, and spending.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Dividend Stocks

A worker gives a business presentation.
Dividend Stocks

TSX Communications in April 2024: The Best Stocks to Buy Right Now

Here are two of the best TSX communication stocks you can buy in April 2024 and hold for years to…

Read more »

Man considering whether to sell or buy
Dividend Stocks

Royal Bank of Canada Stock: Buy, Sell, or Hold?

Royal Bank of Canada (TSX:RY) has a high dividend yield. Should you buy it?

Read more »

Businessman looking at a red arrow crashing through the floor
Dividend Stocks

BCE’s Stock Price Has Fallen to its 10-Year Low of $44: How Low Can it Go?

BCE stock price has dipped 39% in two years and shows no signs of growth in the next few months.…

Read more »

Dollar symbol and Canadian flag on keyboard
Dividend Stocks

Invest $10,000 in This Dividend Stock for $3,974.80 in Passive Income

This dividend stock gives you far more passive income than just from dividends alone, so consider it if you want…

Read more »

Payday ringed on a calendar
Dividend Stocks

This 6% Dividend Stock Pays Cash Every Month

Can a 6% dividend yield help you build a monthly retirement income? An investment made right can help you build…

Read more »

Payday ringed on a calendar
Dividend Stocks

Passive Income: How Much Should You Invest to Earn $1,000 Every Month?

These three monthly-paying dividend stocks can help you earn a monthly passive income of $1,000.

Read more »

Dividend Stocks

3 Dividend Stocks to Double Up on Right Now

Some of these dividend stocks will take longer to recover than others, but they'll certainly pay you to stick around.

Read more »

TFSA and coins
Dividend Stocks

TFSA Passive Income: How Much to Invest to Earn $250/Month

Want to earn $250/month of tax-free passive income? Here are four Canadian dividend stocks to look at buying in your…

Read more »